טוען...
Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness
BACKGROUND: Multiple myeloma (MM) is the second most common hematological cancer worldwide and has significant morbidity and mortality and is increasing in incidence. While MM management costs are considerable, specific economic data at the country level remain scarce. OBJECTIVE: This study assesses...
שמור ב:
| הוצא לאור ב: | Pharmacoeconomics |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8079298/ https://ncbi.nlm.nih.gov/pubmed/33517511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-020-00993-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|